Pediatric Pulmonology, Allergy and Immunology

We are committed to advancing the understanding and care of complex respiratory and immunologic conditions in children through integrated clinical practice, research and education. Our faculty lead efforts in the diagnosis and treatment of diseases such as bronchopulmonary dysplasia, cystic fibrosis, asthma and rare interstitial lung disorders, while also addressing a broad spectrum of allergic and immunologic conditions. 

With strengths in both basic and translational research, we actively participate in multicenter clinical trials and are nationally recognized through affiliations with organizations such as the American Thoracic Society and the Cystic Fibrosis Foundation. 

Our division is deeply engaged in academic development, having delivered over 50 professional presentations in the past three years and continually expanding initiatives in research, procedural skills training and innovative medical education. This dynamic and collaborative environment makes our division a leader in both clinical care and academic excellence across the region.

By the Numbers

6

Number of Faculty 

62

Publications & Presentation since 2022

$17M

Research Funding 

Explore Pediatric Pulmonology, Allergy and Immunology

We cultivate a vibrant academic environment that empowers faculty and fellows and improves health outcomes for the children and families we serve. Actively participating in multicenter clinical trials, particularly those focused on pediatric pulmonary diseases, we contribute to groundbreaking, collaborative research that directly informs and enhances patient care. Our efforts ensure access to state-of-the-art therapies while strengthening evidence-based practices. We are equally committed to advancing medical education through forward-thinking teaching strategies, dedicated mentorship and procedural skills training that uphold the highest standards of clinical excellence.